SSTR5
Somatostatin receptor type 5
Also known as: SSR5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35346
- Gene
- SSTR5
- Ensembl
- ENSG00000162009
- Chromosome
- 16
- Canonical length
- 364 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Somatostatin and its related peptide cortistatin exert multiple biological actions on normal and tumoral tissue targets by interacting with somatostatin receptors (SSTRs). The protein encoded by this gene is one of the SSTRs, which is a multi-pass membrane protein and belongs to the G-protein coupled receptor 1 family. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase, and different regions of this receptor molecule are required for the activation of different signaling pathways. A mutation in this gene results in somatostatin analog resistance. Alternatively spliced transcript variants have been identified in this gene.[provided by RefSeq, Feb 2010]
Canonical amino-acid sequenceUniProt
364 residues, UniProt reviewed canonical sequence.
>P35346|SSTR5
1 MEPLFPASTP SWNASSPGAA SGGGDNRTLV GPAPSAGARA VLVPVLYLLV CAAGLGGNTL
61 VIYVVLRFAK MKTVTNIYIL NLAVADVLYM LGLPFLATQN AASFWPFGPV LCRLVMTLDG
121 VNQFTSVFCL TVMSVDRYLA VVHPLSSARW RRPRVAKLAS AAAWVLSLCM SLPLLVFADV
181 QEGGTCNASW PEPVGLWGAV FIIYTAVLGF FAPLLVICLC YLLIVVKVRA AGVRVGCVRR
241 RSERKVTRMV LVVVLVFAGC WLPFFTVNIV NLAVALPQEP ASAGLYFFVV ILSYANSCAN
301 PVLYGFLSDN FRQSFQKVLC LRKGSGAKDA DATEPRPDRI RQQQEATPPA HRAAANGLMQ
361 TSKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SSTR5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 3.9 nTPM
Expression across tissuesHPA
Tissue
- kidney: 3.9 nTPM
- blood vessel: 2.6 nTPM
- heart muscle: 2.4 nTPM
- adrenal gland: 2.1 nTPM
- pituitary gland: 2.1 nTPM
- salivary gland: 1 nTPM
Single-cell type
- retinal horizontal cells: 48 nCPM
- neuroendocrine cells: 16 nCPM
- somatotrophs: 7.3 nCPM
- lactotrophs: 4.4 nCPM
- epididymal efferent duct ciliated cells: 3.4 nCPM
- pancreatic islet cells: 2.9 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 2.6 nTPM
- cerebral cortex: 0.9 nTPM
- hippocampal formation: 0.6 nTPM
- midbrain: 0.6 nTPM
- medulla oblongata: 0.5 nTPM
- spinal cord: 0.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.59
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to glucocorticoid stimulus
- G protein-coupled receptor signaling pathway
- G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
- glucose homeostasis
- negative regulation of cell population proliferation
- neuropeptide signaling pathway
- positive regulation of cytokinesis
- regulation of insulin secretion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SSTR5 as an antibody target. Whether an autoantibody or antibody against SSTR5 could matter depends on whether native SSTR5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SSTR5 is annotated at the cell surface, where native SSTR5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SSTR5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...